Stable transduction of genetic material, in combination with sensitive meth
odologies for in vivo study of cell physiology, provides an opportunity to
efficiently evaluate the functions of regulatory proteins. To dissect the m
inimal therapeutic function of such proteins, we have stably expressed prot
ein microdomains as fusions, composed of short peptides, and detected speci
fic subfunctions distinct from holoprotein function, using flow cytometry a
nd other techniques. We demonstrate that retroviral delivery of the 24-amin
o-acid proliferating cell nuclear antigen-binding motif (p21C), derived fro
m the C-terminus of the cell cycle inhibitor protein, p21, is sufficient to
induce cell cycle arrest. Cells expressing this peptide motif reversibly e
xecute both G1- and G2-checkpoint controls that are normally activated subs
equent to Interference with DNA synthesis. The p21C effect is distinct from
results obtained with an intact p21 protein that: also binds cyclin-CDK co
mplexes and arrested cells exclusively at the G1/S transition. Thus, microd
omains can exert unique biological effects compared to the parental molecul
es from which they were derived. To further evaluate the peptide delivery s
trategy, we analyzed the role of various kinases in IgE-mediated stimulatio
n of mast cell exocytosis. Primary bone marrow-derived mast cells were tran
sduced with retroviral constructs encoding short-kinase inhibitor motifs an
d analyzed by flow cytometry for effects on exocytosis. We found that a spe
cific protein kinase A (PKA) inhibitor peptide suppressed IgE-mediated stim
ulation of mast cell exocytosis. This anti-exocytotic effect was mimicked b
y a small molecule inhibitor of PKA (KT5720). Thus, the ability to express
protein microdomains can be a powerful means to subtly perturb cellular phy
siology in manners that reveal new paths for therapeutic intervention. We b
elieve that such approaches might allow for new forms of gene therapy to be
come available.